Could doses of insulin via nasal spray be one way to ward off the symptom of memory loss for Alzheimer patients? Time Magazine reports that Suzanne Craft, a psychiatrist at the University of Washington in Seattle and head of the memory disorders clinic at the Veterans Affairs Puget Sound Health Care System, has conducted a small study where insulin or a placebo was delivered to a patient via nasal spray twice a day. Through this new innovative delivery method, which sent the medicine to the brain and central nervous system faster, and studies showed those receiving the insulin has better overall performing brain functions. Those also receiving insulin were also better able to process their glucose in their brains, which the drug is imperative brain perform cognitive functions.
This year at Drug Delivery Partnerships this January, there will be a focus on new formulation development strategies to accelerate drugs to market and lengthen life cycles for long term profitability. Could insulin be valuable for more than just diabetes in a new delivery method? Discuss this with other Drug Delivery Professionals at DDP 2012. For more information, download the brochure here.
What other drugs stand out to you that have been delivered in an alternate method and improved the quality of life?
No comments:
Post a Comment